What is the treatment for dyshidrotic eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Dyshidrotic Eczema

For dyshidrotic eczema, the first-line treatment is high-potency topical corticosteroids for short periods, followed by medium to low-potency options for maintenance, with PUVA therapy or alitretinoin considered for severe or recalcitrant cases. 1

First-Line Treatment Options

Topical Therapies

  • Topical corticosteroids:

    • Use high-potency topical corticosteroids for short periods (2-4 weeks) on thickened areas in severe cases 1
    • Apply medium-potency topical corticosteroids once daily for mild to moderate cases 1
    • Use low-potency topical corticosteroids for sensitive areas like the face 1
    • Once-daily application of potent topical corticosteroids is as effective as twice-daily application 2
  • Emollients and moisturizers:

    • Apply liberally and frequently, especially after bathing 1
    • Use the "soak and smear" technique for chronic phase 1
    • Consider occlusion with cotton gloves at night after moisturizer application 1
  • Topical calcineurin inhibitors:

    • Topical tacrolimus (0.1%) is an effective alternative to corticosteroids 3
    • Can be used for rotational therapy with topical corticosteroids to minimize side effects 3

Second-Line Treatment Options

Phototherapy

  • PUVA (Psoralen plus UVA) therapy:
    • Oral PUVA has been shown to be superior to UVB for hand eczema 4
    • Oral PUVA can achieve significant improvement or clearance in 81-86% of patients with hand and foot eczema 4
    • Topical PUVA has shown variable results with improvement rates of 58-81% in uncontrolled studies, but less convincing evidence in comparative studies 4

Systemic Treatments

  • Alitretinoin:
    • Recommended for chronic or recalcitrant cases 1
    • Particularly effective for severe hand eczema that doesn't respond to topical treatments

Management of Secondary Complications

  • Bacterial infections:

    • Obtain bacterial cultures if secondary infection is suspected (often Staphylococcus aureus) 1, 5
    • Administer appropriate antibiotics based on culture results 1
    • Be aware that prolonged use of topical corticosteroids can increase infection risk 5
  • Severe itching:

    • Consider oral antihistamines such as cetirizine, loratadine, or fexofenadine 1

Prevention and Maintenance

  • Trigger identification and avoidance:

    • Identify and eliminate triggering substances 1
    • Consider metal allergy as a potential trigger 6
    • Use after-work creams for protection 1
  • Proactive maintenance therapy:

    • Weekend (proactive) application of topical corticosteroids significantly reduces relapse rates (from 58% to 25%) 2
    • Apply topical corticosteroids twice weekly to previously affected areas to prevent relapse 1

Treatment Algorithm for Dyshidrotic Eczema

  1. Acute phase:

    • High-potency topical corticosteroids once daily for 2-4 weeks
    • Liberal use of emollients
    • Avoid identified triggers
  2. If inadequate response or severe disease:

    • Consider PUVA therapy (oral PUVA preferred over topical) 4
    • Consider alitretinoin for chronic hand eczema 1
  3. Maintenance phase:

    • Weekend (proactive) application of topical corticosteroids
    • Daily emollients
    • Rotational therapy with topical tacrolimus may be beneficial 3

Important Caveats and Pitfalls

  • Corticosteroid-related concerns:

    • Avoid prolonged use of potent topical corticosteroids due to risk of skin thinning 2
    • Risk of developing side effects depends on potency, duration of use, and volume applied 5
    • Clobetasol propionate (very potent) should be limited to maximum 2 weeks of use 5
    • Be aware of the cumulative depot effect of potent corticosteroids 5
  • Efficacy considerations:

    • Relapse rates are high after discontinuation of treatment 4, 3
    • Complete remission is difficult to achieve with conventional therapies alone 7
    • Most patients (14 of 16 in one study) experience recurring symptoms within 3 weeks after active treatment 3
  • Treatment resistance:

    • For cases refractory to multiple forms of topical and systemic agents, low-dose radiation therapy has shown complete resolution in some cases, though this is not a first-line approach 7

References

Guideline

Dermatological Conditions of the Skin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impetiginized Dyshidrotic Eczema.

Open access Macedonian journal of medical sciences, 2017

Research

Dyshidrotic Eczema and Its Relationship to Metal Allergy.

Current problems in dermatology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.